Association Between Oxidative–Inflammation Biomarkers and Incident Chronic Kidney Disease in People with High Cardiovascular Risk: A Nested Case–Control Study
<b>Aim</b>: To assess oxidative-inflammatory biomarker prediction of incident CKD after 1-year follow-up in a population with overweight/obesity and metabolic syndrome. <b>Methods</b>: Prospective nested case-control study comprising 117 CKD incident cases and 117 matched controls free of CKD after 1-year follow-up conducted in 55-75-year-old participants. Controls were time-matched 1:1 to cases by intervention group, age (≤65 vs. >65 years), and sex. Serum creatinine (SCr), cystatin C (CyC), and urine albumin-to-creatinine ratio (UACR) were measured at baseline, and CKD Epidemiology Collaboration equations for Caucasians were used to assess SCr, CyC, and CyC-SCr-based estimated Glomerular Filtration Rate (eGFR). Baseline levels of malondialdehyde (MDA), carbonyls, tumour necrosis factor alpha (TNFα), interleukin (IL)-1β, IL-1ra, IL-6, monocyte chemoattractant protein 1 (MCP-1), and leptin were determined from fasting serum samples. An inflammatory-oxidative stress score based on these biomarkers was calculated. Incident CKD was defined by eGFR-SCr <60 mL/min/1.73 m<sup>2</sup>, and/or UACR ≥30 mg/g in the absence of CKD at baseline. <b>Results</b>: UACR positively correlated with pro-inflammatory markers (IL-1β; TNFα) and oxidative damage marker (MDA); eGFR-cyC showed negative correlations with IL-1β and IL-1ra, and eGFR-SCr with leptin. The odds ratios (OR; 95% CI) for incident CKD in the highest vs. the lowest tertile of IL-1ra IL-6 and TNFα were (2.22; 1.22-4.04), (7.03; 2.88-17.14), and (3.79; 1.79-8.02), respectively. The inflammatory-oxidative stress score was associated with incident CKD (OR per 1-SD increment: 2.06; 1.49-2.83). <b>Conclusions</b>: Inflammatory/oxidative stress is associated with CKD incidence in individuals with high cardiovascular risk, underscoring the importance in identify early inflammation to prevent this disease.
Authors
- Josep A. Tur (ORCID: https://orcid.org/0000-0002-6940-0761)
- Cristina Bouzas (ORCID: https://orcid.org/0000-0002-1407-8461)
- José Manuel Santos‐Lozano (ORCID: https://orcid.org/0000-0001-7097-5653)
- Jordi Salas‐Salvadó (ORCID: https://orcid.org/0000-0003-2700-7459)
- Miguel Ruiz‐Canela (ORCID: https://orcid.org/0000-0002-7684-2787)
- Andrés Díaz‐López (ORCID: https://orcid.org/0000-0002-7500-5629)
- José López‐Miranda (ORCID: https://orcid.org/0000-0002-8844-0718)
- Jesús Vioqué (ORCID: https://orcid.org/0000-0002-2284-148X)
- Margalida Monserrat-Mesquida (ORCID: https://orcid.org/0000-0002-8856-135X)
- Aurora Bueno‐Cavanillas (ORCID: https://orcid.org/0000-0002-0649-3016)
- Dora Romaguera (ORCID: https://orcid.org/0000-0002-5762-8558)
- Francisco José Tinahones (ORCID: https://orcid.org/0000-0001-6871-4403)
- Antoni Sureda (ORCID: https://orcid.org/0000-0001-8656-6838)
- Maria Magdalena Quetglas‐Llabrés (ORCID: https://orcid.org/0000-0003-4155-7780)
- Sebastián Mas (ORCID: https://orcid.org/0000-0001-6604-3327)
- Silvia García (ORCID: https://orcid.org/0000-0003-3534-1588)
- Nancy Babió (ORCID: https://orcid.org/0000-0003-3527-5277)
- Pilar Matía‐Martín (ORCID: https://orcid.org/0000-0001-9844-3755)
- J. Alfredo Martínéz (ORCID: https://orcid.org/0000-0001-5218-6941)
- M. Olga Garcia-Fernandez (ORCID: https://orcid.org/0009-0007-9611-4529)
- Ramón Estruch (ORCID: https://orcid.org/0000-0003-1260-4445)
Institutions
- Madrid Institute for Advanced Studies (ES)
- Universidad de Valladolid (ES)
- Universitat de Miguel Hernández d'Elx (ES)
- Instituto de Salud Carlos III (ES)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Instituto Maimónides de Investigación Biomédica de Córdoba (ES)
- Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES)
- Institut de Recerca Biomèdica Catalunya Sud (ES)
- Instituto de Investigación Biosanitaria de Granada (ES)
- Health Research Institute of the Balearic Islands (ES)
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Research Institute of Health Sciences (ES)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
- Hospital Clínico Universitario Virgen de la Victoria (ES)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
- Universitat de les Illes Balears (ES)
- University of Córdoba (ES)
- Universitat Rovira i Virgili (ES)
- Universidad Autónoma de Madrid (ES)
- Universidad de Sevilla (ES)
- Universidad de Navarra (ES)
- Universidad de León (ES)
Publication Details
- Journal
- Antioxidants
- Published
- 2025-08-08
- DOI
- https://doi.org/10.3390/antiox14080975
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición
- Instituto de Salud Carlos III
- European Regional Development Fund